{"denomUnitsSelected":"Participants","description":"A descriptive analysis of pharmacokinetic parameters of LOXO-101 (larotrectinib) will be performed to define systemic exposure, drug clearance, and other pharmacokinetic parameters. The pharmacokinetic parameters will be summarized with simple summary statistics, including means, medians, ranges, and standard deviations (if numbers and distribution permit). All these analyses will be descriptive and exploratory and hypotheses generating in nature.","reportingStatus":"NOT_POSTED","timeFrame":"Pre-dose, 1, 2, 4, and 6-8 hours after morning dose of day 1 cycle 1 and pre-dose of day 1 cycle 2","title":"Pharmacokinetics of Larotrectinib","type":"OTHER_PRE_SPECIFIED"}